Key Highlights
- The forward Dividend Yield is 17.87%, with monthly distributions of USD 0.06 per share declared for January through March 2027.
- Distributions declared per share were USD 0.27 for the third quarter, compared with USD 0.33 a year earlier.
- Net asset value per share was USD 5.56 at September 30, compared with USD 6.98 at December 31, 2025.
- Management said net Investment income was USD 0.19 per share, covering regular distributions in the quarter.
Horizon Technology Finance Corporation (NASDAQ:HRZN) carries a forward dividend yield of 17.87%. Management said the Board declared monthly distributions of USD 0.06 per share payable in January, February and March of 2027. Distributions declared per share were USD 0.27 for the third quarter, and net asset value per share was USD 5.56 at September 30, 2026.
Dividend Program and Shareholder Returns
The Board declared monthly distributions of USD 0.06 per share payable in January, February and March of 2027. For the months of October and November 2026, the filing lists distributions declared on July 30, 2026 of USD 0.03 and USD 0.06 per share, payable November 16 and December 15, 2026 to holders of record on October 16 and November 17, 2026.
Distributions declared per share were USD 0.27 for the three months and USD 0.72 for the nine months ended September 30, 2026, compared with USD 0.33 and USD 0.99 in the prior-year periods. Distributions payable were USD 5.9 million at September 30, compared with USD 15.1 million at December 31, 2025.
Management said net investment income of USD 0.19 per share covered the regular distributions in the quarter. The trailing twelve month dividend yield is 24.07%, shown for information.
About the Company
Horizon Technology Finance Corporation is a Business Development Company listed on the Nasdaq Global Select Market that provides venture loans to life science and technology companies. Total Assets were USD 778.7 million at September 30, 2026, compared with USD 811.1 million at December 31, 2025. Total net assets were USD 362.1 million, compared with USD 318.5 million, and borrowings were USD 402.7 million, compared with USD 473.0 million.
Investment Income Mix and Net Investment Income
Total investment income was USD 24.1 million for the third quarter, compared with USD 26.3 million a year earlier, and USD 73.2 million for the nine months, compared with USD 75.4 million. Interest income from non-affiliate investments was USD 21.1 million, compared with USD 23.5 million, and prepayment fee income was USD 1.6 million, compared with USD 1.0 million.
Interest expense was USD 7.8 million, compared with USD 7.9 million, and the base management fee was USD 3.0 million, compared with USD 2.7 million. Net investment income was USD 12.3 million, compared with USD 14.0 million, and USD 28.6 million for the nine months, compared with USD 36.2 million.
Net Decrease in Net Assets and Net Asset Value
The net decrease in net assets resulting from operations was USD 28.2 million, or USD 0.43 per basic share, for the third quarter, compared with a net increase of USD 30.7 million, or USD 0.71 per basic share. For the nine months, the net decrease was USD 62.7 million, or USD 1.05 per share, compared with USD 11.5 million, or USD 0.28.
Management said net asset value per share was down USD 0.67 for the quarter, primarily due to write-downs of certain investments. Weighted average basic shares were 66.3 million, compared with 43.1 million.
Repurchases, Leverage and Liquidity
Management said the company repurchased just over 2 million shares of common stock in the quarter at an average price of USD 4.90 under its USD 20 million stock repurchase program. Management said the onboarding Debt investment yield was 12.6% in the third quarter.
Management said available Liquidity was USD 211 million at September 30, consisting of USD 108 million in cash and USD 103 million in available borrowing base capacity, and that the Debt-to-Equity Ratio was 1.12 to 1, or 0.82 to 1 net of cash.
Subsequent to quarter end, Glass Routes, LLC prepaid USD 7.5 million of principal on its venture Loan on October 13, and the company funded a USD 10.0 million debt investment to Pelthos Therapeutics, Inc. on October 30.
Outlook
The 17.87% forward dividend yield and the USD 0.06 per share monthly distributions declared for January through March 2027 are the dividend facts on record. Net investment income per share, net asset value per share, net leverage, and portfolio write-downs are the relevant considerations.






Please wait processing your request...